Your browser doesn't support javascript.
loading
Patritumab deruxtecan in untreated hormone receptor-positive/HER2-negative early breast cancer: final results from part A of the window-of-opportunity SOLTI TOT-HER3 pre-operative study.
Oliveira, M; Falato, C; Cejalvo, J M; Vila, M Margelí; Tolosa, P; Salvador-Bofill, F J; Cruz, J; Arumi, M; Luna, A M; Guerra, J A; Vidal, M; Martínez-Sáez, O; Paré, L; González-Farré, B; Sanfeliu, E; Ciruelos, E; Espinosa-Bravo, M; Pernas, S; Izarzugaza, Y; Esker, S; Fan, P-D; Parul, P; Santhanagopal, A; Sellami, D; Villacampa, G; Ferrero-Cafiero, J M; Pascual, T; Prat, A.
Afiliação
  • Oliveira M; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Vall d'Hebron University Hospital, and Breast Cancer Group, Vall D'Hebron Institute of Oncology (VHIO), Barcelona. Electronic address: https://twitter.com/MOliveira_MD.
  • Falato C; SOLTI Cancer Research Group, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
  • Cejalvo JM; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Hospital Clínico Universitario de Valencia, Valencia.
  • Vila MM; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, ICO - Institut Català d'Oncologia Badalona (Hospital Universitario Germans Trias i Pujol), Badalona.
  • Tolosa P; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Hospital 12 de Octubre, Madrid.
  • Salvador-Bofill FJ; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Hospital Universitario Virgen del Rocio, Sevilla.
  • Cruz J; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife.
  • Arumi M; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Vall d'Hebron University Hospital, and Breast Cancer Group, Vall D'Hebron Institute of Oncology (VHIO), Barcelona.
  • Luna AM; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department; Centro Integral Oncológico Clara Campal HM (CIOCC), Madrid.
  • Guerra JA; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Hospital de Fuenlabrada, Fuenlabrada.
  • Vidal M; SOLTI Cancer Research Group, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona.
  • Martínez-Sáez O; SOLTI Cancer Research Group, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona.
  • Paré L; SOLTI Cancer Research Group, Barcelona.
  • González-Farré B; SOLTI Cancer Research Group, Barcelona; Pathology Department, Hospital Clinic of Barcelona, Barcelona.
  • Sanfeliu E; SOLTI Cancer Research Group, Barcelona; Pathology Department, Hospital Clinic of Barcelona, Barcelona.
  • Ciruelos E; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Hospital 12 de Octubre, Madrid.
  • Espinosa-Bravo M; SOLTI Cancer Research Group, Barcelona; Breast Cancer Surgical Unit, Vall d'Hebron University Hospital, Barcelona.
  • Pernas S; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Catalan Institute of Oncology - ICO, Breast Cancer Group; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona.
  • Izarzugaza Y; SOLTI Cancer Research Group, Barcelona; Medical Oncology Department, Fundación Jimenez Díaz, Madrid, Spain.
  • Esker S; Research and Development, Daiichi Sankyo, Inc, Basking Ridge, USA.
  • Fan PD; Research and Development, Daiichi Sankyo, Inc, Basking Ridge, USA.
  • Parul P; Research and Development, Daiichi Sankyo, Inc, Basking Ridge, USA.
  • Santhanagopal A; Research and Development, Daiichi Sankyo, Inc, Basking Ridge, USA.
  • Sellami D; Research and Development, Daiichi Sankyo, Inc, Basking Ridge, USA.
  • Villacampa G; SOLTI Cancer Research Group, Barcelona.
  • Ferrero-Cafiero JM; SOLTI Cancer Research Group, Barcelona.
  • Pascual T; SOLTI Cancer Research Group, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona.
  • Prat A; SOLTI Cancer Research Group, Barcelona; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Medical Oncology Department, Hospital Clinic de Barcelona, Barcelona. Electronic address: ALPRAT@clinic.cat.
Ann Oncol ; 34(8): 670-680, 2023 08.
Article em En | MEDLINE | ID: mdl-37211044
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article